The proportion of CD133+ and CD44+ tumor cells varied greatly between models (Fig. 2A), consistent with the wide variation in the proportion of positive cells between tumors noted in the original publications identifying each of these CSC markers [24], [25]. Here, PROM1 is linked to neoplasm.